Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y(1))- and GRP-Receptors—An Improvement for Breast Cancer Imaging?

Ítems similars

• Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y1)- and GRP-Receptors—An Improvement for Breast Cancer Imaging?
  per: Alicia Vall-Sagarra, et al.
  Publicat: (2018-07-01)
• Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy
  per: Judmann, Benedikt, et al.
  Publicat: (2020)
• Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin α(v)β(3) and the MC1 Receptor—Suitable for the Specific Visualization of Melanomas?
  per: Cheng, Xia, et al.
  Publicat: (2021)
• iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings
  per: Shanna Litau, et al.
  Publicat: (2018-10-01)
• iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with (68)Ga and (64)Cu: Unexpected Findings
  per: Litau, Shanna, et al.
  Publicat: (2018)